Category: Press Releases

CorTec Receives Second FDA Breakthrough Device Designation for Brain Interchange™

31.08.2026

CorTec's Brain Interchange™ BCI System Enables Stroke Patient to Control Computer with his Mind

29.04.2026

CorTec’s Brain Interchange™ Accepted into FDA Total Product Life Cycle Advisory Program (TAP) - Third patient successfully implanted at Harborview Medical Center as NIH-funded stroke trial advances

23.04.2026

CorTec Receives FDA Breakthrough Device Designation for Its Brain Interchange™

08.04.2026

CorTec Announces Successful Second Human Implantation of Its Brain-Computer Interface (BCI) System

10.02.2026

CorTec Announces Neurotech Milestone: First Human Implantation of a Brain-Computer Interface made in Germany

29.07.2025

Marking a New Era in Medical Device Development – CorTec Announces Strategic Partnership with US-based Heraeus Medevio

19.02.2025

Next Important Milestone Reached for First-in-Human Implantation of the CorTec Brain Interchange™ System as a Therapeutic Brain-Computer Interface

CorTec has announced today that Institutional Review Board from University of Washington (IRB) has approved the Feasibility study for …

14.10.2024

FDA approves Investigational Device Exemption for Early Feasibility Study for rehabilitation of stroke patients

CorTec has announced today that the US Food and Drug Administration (FDA) has approved an Investigational Device Exemption (IDE) …

23.05.2024